EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Traders Buy High Volume of Call Options on Novavax (NASDAQ:NVAX)
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Rating of "Hold" from Analysts
Novavax (NASDAQ:NVAX) Stock Price Expected to Rise, TD Cowen Analyst Says - Daily Political
Novavax Surpasses Revenue Expectations in Q1, Surges Over 14%, ETPharma
Q1 2026 Novavax Inc Earnings Call Transcript
Novavax (NASDAQ:NVAX) Issues Quarterly Earnings Results
Why Novavax (NVAX) Is Up 17.4% After Q1 2026 Revenue Plunge And Profit Swing To Loss
Novavax Q1 Earnings Call Highlights
Novavax (NASDAQ:NVAX) Price Target Raised to $9.00 at TD Cowen
Novavax (NASDAQ:NVAX) Shares Up 12.9% After Strong Earnings
Novavax (NASDAQ:NVAX) Surprises With Strong Q1 CY2026, Stock Soars
Novavax beats first-quarter revenue estimates on strength in vaccine deals
Is It Time To Reconsider Novavax (NVAX) After A 95% Five Year Share Price Fall
Assessing Novavax (NVAX) Valuation As Licensing Pivot And Key Vaccine Readout Approach
Novavax (NVAX) to Release Earnings on Wednesday
A Look At Novavax (NVAX) Valuation As It Shifts To Licensing And Awaits Combo Vaccine Data
Is Novavax, Inc. (NVAX) A Good Stock To Buy Now?
Novavax to Report First Quarter 2026 Financial Results on Ma
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
1 Cash-Heavy Stock to Target This Week and 2 We Ignore
Why Novavax (NVAX) Is Down 7.0% After Crushing Q4 Revenue And Earnings Forecasts - And What's Next - Simply Wall St News
Novavax, Inc. (NVAX) PT Increased as B. Riley Sees Governance-Driven Catalysts Ahead
FY2028 EPS Estimates for Novavax Cut by Zacks Research
Zacks Research Issues Negative Forecast for Novavax Earnings - Daily Political
Is It Time To Reconsider Novavax (NVAX) After Recent Share Price Weakness?
Spotting Winners: AbbVie (NYSE:ABBV) And Therapeutics Stocks In Q4
Head-To-Head Contrast: Synlogic (NASDAQ:SYBX) versus Novavax (NASDAQ:NVAX)
Assessing Novavax (NVAX) Valuation After Recent Share Price Volatility And Licensing Expectations
Chandrakant Lahariya | Flu-COVID Combo Vaccines: An Idea Whose Time Has Not Yet Arrived
Novavax, Inc. (NASDAQ:NVAX) Receives Consensus Recommendation of "Hold" from Analysts
Is It Time To Reassess Novavax (NVAX) After Recent Volatility And Partnership News
Is Novavax (NVAX) Being Pulled Between R&D Ambitions and Activist Demands for Discipline? - Simply Wall St News
Sanofi becomes market authorization holder for Nuvaxovid® in Canada, expanding COVID-19 vaccine choices for Canadians
